CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1294 entries

View as:

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Phase: N/A Priority: Normal

NCT ID: NCT06571383 Org: User:

Start: 09/17/24 End: 11/15/31 Due: 11/15/32

A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02962440 Org: User:

Start: 11/30/16 End: 01/31/17 Due: 01/31/18

A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal

NCT ID: NCT03374774 Org: User:

Start: 11/13/17 End: 07/04/18 Due: 07/04/19

A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

Phase: N/A Priority: Normal

NCT ID: NCT03842202 Org: User:

Start: 02/15/19 End: 11/04/19 Due: 11/04/20

Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics

Phase: N/A Priority: Normal

NCT ID: NCT00992537 Org: User:

Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00715663 Org: User:

Start: 02/28/07 End: 12/31/07 Due: 12/31/08

Compassionate Use of Concizumab if You Have Haemophilia

Phase: N/A Priority: Normal

NCT ID: NCT04921956 Org: User:

Start: - End: - Due: -

Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT01477632 Org: User:

Start: 03/31/05 End: 06/30/05 Due: 06/30/06

Use of Activated Recombinant FVII in Spinal Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00102037 Org: User:

Start: 07/31/04 End: 02/28/06 Due: 02/28/07

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Phase: N/A Priority: Normal

NCT ID: NCT06577766 Org: User:

Start: 09/03/24 End: 09/18/25 Due: 09/18/26

Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

Phase: N/A Priority: Normal

NCT ID: NCT03672617 Org: User:

Start: 10/02/18 End: 04/25/19 Due: 04/25/20

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00964418 Org: User:

Start: 08/31/09 End: 11/30/09 Due: 11/30/10

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Phase: N/A Priority: Normal

NCT ID: NCT01676116 Org: User:

Start: 08/29/12 End: 03/11/14 Due: 03/11/15

An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

Phase: N/A Priority: Normal

NCT ID: NCT00934063 Org: User:

Start: 07/31/09 End: 06/30/14 Due: 06/30/15

An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01696266 Org: User:

Start: 09/05/12 End: 12/30/13 Due: 12/30/14

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01511172 Org: User:

Start: 08/31/02 End: 12/31/02 Due: 12/31/03

A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT01973244 Org: User:

Start: 12/16/13 End: 11/04/14 Due: 11/04/15

STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity

Phase: N/A Priority: Normal

NCT ID: NCT03811574 Org: User:

Start: 01/21/19 End: 11/20/20 Due: 11/20/21

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01697618 Org: User:

Start: 04/30/97 End: 11/30/98 Due: 11/30/99

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

Phase: N/A Priority: Normal

NCT ID: NCT01493778 Org: User:

Start: 09/17/12 End: 12/05/18 Due: 12/05/19

Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

Phase: N/A Priority: Normal

NCT ID: NCT03220425 Org: User:

Start: 02/01/01 End: 11/12/01 Due: 11/12/02

Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

Phase: N/A Priority: Normal

NCT ID: NCT00465192 Org: User:

Start: 08/31/94 End: 11/30/95 Due: 11/30/96

Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT01312636 Org: User:

Start: 03/31/11 End: 09/30/14 Due: 09/30/15

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

Phase: N/A Priority: Normal

NCT ID: NCT02918279 Org: User:

Start: 09/29/16 End: 08/08/19 Due: 08/08/20

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01288326 Org: User:

Start: 02/28/11 End: 03/31/13 Due: 03/31/14

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss	NCT06571383	Novo Nordisk A/S	user2@example.com	None	2024-09-17	2031-11-15	2032-11-15	-	-	2025-07-14
A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects	NCT02962440	Novo Nordisk A/S	user2@example.com	None	2016-11-30	2017-01-31	2018-01-31	-	-	2025-07-14
A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)	NCT03374774	Novo Nordisk A/S	user2@example.com	None	2017-11-13	2018-07-04	2019-07-04	-	-	2025-07-14
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity	NCT03842202	Novo Nordisk A/S	user2@example.com	None	2019-02-15	2019-11-04	2020-11-04	-	-	2025-07-14
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics	NCT00992537	Novo Nordisk A/S	user2@example.com	None	2009-10-31	2010-01-31	2011-01-31	-	-	2025-07-14
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes	NCT00715663	Novo Nordisk A/S	user2@example.com	None	2007-02-28	2007-12-31	2008-12-31	-	-	2025-07-14
Compassionate Use of Concizumab if You Have Haemophilia	NCT04921956	Novo Nordisk A/S	user2@example.com	None	-	-	-	-	-	2025-07-14
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women	NCT01477632	Novo Nordisk A/S	user2@example.com	None	2005-03-31	2005-06-30	2006-06-30	-	-	2025-07-14
Use of Activated Recombinant FVII in Spinal Surgery	NCT00102037	Novo Nordisk A/S	user2@example.com	None	2004-07-31	2006-02-28	2007-02-28	-	-	2025-07-14
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity	NCT06577766	Novo Nordisk A/S	user2@example.com	None	2024-09-03	2025-09-18	2026-09-18	-	-	2025-07-14
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy	NCT03672617	Novo Nordisk A/S	user2@example.com	None	2018-10-02	2019-04-25	2020-04-25	-	-	2025-07-14
A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes	NCT00964418	Novo Nordisk A/S	user2@example.com	None	2009-08-31	2009-11-30	2010-11-30	-	-	2025-07-14
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy	NCT01676116	Novo Nordisk A/S	user2@example.com	None	2012-08-29	2014-03-11	2015-03-11	-	-	2025-07-14
An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®	NCT00934063	Novo Nordisk A/S	user2@example.com	None	2009-07-31	2014-06-30	2015-06-30	-	-	2025-07-14
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes	NCT01696266	Novo Nordisk A/S	user2@example.com	None	2012-09-05	2013-12-30	2014-12-30	-	-	2025-07-14
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes	NCT01511172	Novo Nordisk A/S	user2@example.com	None	2002-08-31	2002-12-31	2003-12-31	-	-	2025-07-14
A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency	NCT01973244	Novo Nordisk A/S	user2@example.com	None	2013-12-16	2014-11-04	2015-11-04	-	-	2025-07-14
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity	NCT03811574	Novo Nordisk A/S	user2@example.com	None	2019-01-21	2020-11-20	2021-11-20	-	-	2025-07-14
Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes	NCT01697618	Novo Nordisk A/S	user2@example.com	None	1997-04-30	1998-11-30	1999-11-30	-	-	2025-07-14
Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A	NCT01493778	Novo Nordisk A/S	user2@example.com	None	2012-09-17	2018-12-05	2019-12-05	-	-	2025-07-14
Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.	NCT03220425	Novo Nordisk A/S	user2@example.com	None	2001-02-01	2001-11-12	2002-11-12	-	-	2025-07-14
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis	NCT00465192	Novo Nordisk A/S	user2@example.com	None	1994-08-31	1995-11-30	1996-11-30	-	-	2025-07-14
Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency	NCT01312636	Novo Nordisk A/S	user2@example.com	None	2011-03-31	2014-09-30	2015-09-30	-	-	2025-07-14
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity	NCT02918279	Novo Nordisk A/S	user2@example.com	None	2016-09-29	2019-08-08	2020-08-08	-	-	2025-07-14
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes	NCT01288326	Novo Nordisk A/S	user2@example.com	None	2011-02-28	2013-03-31	2014-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance